TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia (Q40588855)

21 September 2017

TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia (English)

1 reference

21 September 2017

0 references

cervix uterine cancer

1 reference

based on heuristic

inferred from title

author

Renske D. Steenbergen

0 references

Chris J L M Meijer

6

object named as

Chris J L M Meijer

1 reference

21 September 2017

7

Peter J F Snijders

1 reference

21 September 2017

Renske D M Steenbergen

1

1 reference

21 September 2017

Debbie Kramer

2

1 reference

21 September 2017

Boudewijn J M Braakhuis

3

1 reference

21 September 2017

Peter L Stern

4

1 reference

21 September 2017

René H M Verheijen

5

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

Journal of the National Cancer Institute

21 September 2017

1 reference

21 September 2017

96

1 reference

21 September 2017

294-305

1 reference

21 September 2017

4

1 reference

The 2001 Bethesda System: terminology for reporting results of cervical cytology

21 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH031

Papillomaviruses and cancer: from basic studies to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH031

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH031

Epidemiologic classification of human papillomavirus types associated with cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH031

Progression of human papillomavirus type 18-immortalized human keratinocytes to a malignant phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH031

Telomerase suppression by chromosome 6 in a human papillomavirus type 16-immortalized keratinocyte cell line and in a cervical cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH031

Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH031

Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH031

Loss of heterozygosity occurs at the D11S29 locus on chromosome 11q23 in invasive cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH031

TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH031

The tumor suppressor protein TSLC1 is involved in cell-cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH031

Multiple mechanisms underlie HLA dysregulation in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH031

HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH031

A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH031

Identification of p53 gene mutations in bladder cancers and urine samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH031

Schedule-dependent therapeutic efficacy of the combination of gemcitabine and cisplatin in head and neck cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH031

Telomerase activity in high-grade cervical lesions is associated with allelic imbalance at 6Q14-22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH031

Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH031

Aberrant methylation of the 5' CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH031

Hypermethylation of the TSLC1 Gene Promoter in Primary Gastric Cancers and Gastric Cancer Cell Lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH031

Analysis of 11q21-24 loss of heterozygosity candidate target genes in breast cancer: indications of TSLC1 promoter hypermethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH031

Markers for early detection of cancer: statistical guidelines for nested case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH031

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJH031

1 reference

21 September 2017

1 reference